# Prevalence of Microorganisms in Atherosclerotic Plaques of Coronary Arteries: A Systematic Review and Meta-Analysis

Authors: Iman Razeghian-Jahromi; Zahra Elyaspour; Mohammad Javad Zibaeenezhad; Soheil Hassanipour
Journal: Evidence-Based Complementary and Alternative Medicine
 (2022)

---

## Abstract

Background. In this systematic review and meta-analysis, the existence of pathogens in atherosclerotic plaques of coronary arteries was investigated in coronary arteries diseases (CAD) patients. Methods. This study was designed and implemented up to 31 August 2020. The findings present according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) checklist. Two independent reviewers (I.RJ and S.H) performed a comprehensive search on four different English databases including PubMed, ISI, Scopus, and Embase. In order to assess the quality of the articles, a checklist prepared by The Joanna Briggs Institute (JBI) was used. Results. Finally, 44 studies were selected. The prevalence of different microorganisms in coronary arteries were as follows: Aggregatibacter actinomycetemcomitans (46.2%), Campylobacter rectus (43.0%), Chlamydia pneumonia (42.8%), Cytomegalovirus (29.1%), Helicobacter pylori (18.9%), Herpes simplex virus type 1 (5.9%), Porphyromonas gingivalis (42.6%), Prevotella intermedia (47.6%), Tannerella forsythia (43.7%), and Treponema denticola (32.9%). Conclusion. Based on the result of this meta-analysis, Prevotella intermedia and Aggregatibacter actinomycetemcomitans are the most common microorganisms in atherosclerotic plaques of coronary arteries and may have an important role in the development of atherosclerosis.


---

## Body

## 1. Introduction

Cardiovascular disease (CVD) is increasingly challenging people's health, irrespective of age, gender, and race. Coronary artery disease (CAD) is the main culprit in the growing burden of CVD [1]. CAD clinically appeared as the focal thickening of the intima layer due to the formation of atheroma [1]. Atheroma is the main content of atherosclerotic plaque constituting macrophages, cholesterol, smooth muscle cells, and dystrophic calcification [2]. Association of atherosclerosis with both innate and adaptive immunity is evidenced [3]. Chronic inflammation, endothelial dysfunction, and lipid accumulation in the vasculature are hallmarks of atherosclerosis [4].Formation and development of atherosclerosis are feasible in the absence of traditional risk factors [4]. Surprisingly, nearly half of the patients with CVD are free from known cardiovascular risk factors such as hypercholesterolemia, hypertension, smoking, and obesity [5]. In order to reduce related morbidity and mortality, precise identification of all underlying reasons is of paramount importance.Infections involve, at least in part, in CAD initiation and development [1]. Atherosclerosis may be originated from bacterial infection in terms of microbial symbiosis and inflammatory stimulus [6, 7]. Microbial agents contribute to the atherosclerosis process directly by infecting the vascular cells or indirectly by activation of inflammatory cytokines [4]. In this systematic review and meta-analysis, the existence of pathogens in atherosclerotic plaques of coronary arteries was investigated in CAD patients.


## 2. Materials and Methods

### 2.1. Study Design

The present study is a systematic review and meta-analysis investigating the existence of microorganisms isolated from atherosclerotic plaques of coronary arteries. This study was designed and implemented up to 31 August 2020. The findings present according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) checklist.


### 2.2. Information Sources and Search Strategy

Two independent reviewers (IRJ and SH) performed a comprehensive search on four different English databases including PubMed, ISI, Scopus, and Embase. Specific search strategies were designed and used for each database. The included keywords were previous isolated bacterial species (Aggregatibacter actinomycetecomitans, Chlamydiae pneumonia, Campylobacter rectus, Enteroacter hormaechei, Eikenella corrodens, Fusobacterium nucleatum, Fusobacterium necrophorum, Helicobacter pylori, Mycoplasma pneumonia, Porphyromonas endodontalis, Porphyromonas gingivalis, Prevotella intermedia, Prevotella nigrescens, Pseudomonas aeruginosa, Pseudomonas luteola, Streptococcus gordonii, Streptococcus mitis, Streptococcus mutans, Streptococcus oralis, Streptococcus sanguinis, Treponema denticola, Tannerella forsythia, and Veillonella) along with relevant cardiovascular terms (Cardio∗, Cardiovascular, Cardiac, Heart, HF, Heart failure, Atherosclerosis, Athero∗, Arteri∗, Atherosclerotic, Coronary, atherosclerotic plaques, Endocarditis, Cardit∗, Aortic, Aort∗, Myocardial, and Myocardi∗).


### 2.3. Eligibility Criteria

Articles were imported into the EndNote software (version X7). Duplicate ones were automatically deleted from the dataset. Eligibility criteria were original studies on human samples published in English reporting microbial footprints in atherosclerotic plaques of coronary arteries. Studies published in other languages other than English, papers without full text, review articles, and articles presented in conferences as abstracts were excluded.


### 2.4. Quality Assessment

In order to assess the quality of the articles, a checklist prepared by The Joanna Briggs Institute (JBI) was used. The purpose of this appraisal is to assess the methodological quality of a study and to determine the extent to which a study has addressed the possibility of bias in its design, conduct, and analysis. All papers were evaluated on the basis of data relevance and methodological rigor.


### 2.5. Screening of the Articles

Primary searching of titles and abstracts was done by IRJ and ZE. They separately extracted data as well as evaluation of the articles’ quality control. In case of ambiguity in one article, the principal investigator issued the final decision.


### 2.6. Data Extraction Form

A predefined checklist was prepared in order to extract data from all eligible articles. This checklist contained the author name, publishing year, country of origin, method of microorganism detection, and prevalence of each isolated microorganism.


### 2.7. Statistical Analysis

Heterogeneity between studies and their combination were checked by the Cochran test andI2 parameter, respectively. In the case of heterogeneity, a random effect model with the inverse variance method was used. Otherwise, the fixed effect model was used. All the analyses were performed by CMA statistical software (ver. 2).


## 2.1. Study Design

The present study is a systematic review and meta-analysis investigating the existence of microorganisms isolated from atherosclerotic plaques of coronary arteries. This study was designed and implemented up to 31 August 2020. The findings present according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) checklist.


## 2.2. Information Sources and Search Strategy

Two independent reviewers (IRJ and SH) performed a comprehensive search on four different English databases including PubMed, ISI, Scopus, and Embase. Specific search strategies were designed and used for each database. The included keywords were previous isolated bacterial species (Aggregatibacter actinomycetecomitans, Chlamydiae pneumonia, Campylobacter rectus, Enteroacter hormaechei, Eikenella corrodens, Fusobacterium nucleatum, Fusobacterium necrophorum, Helicobacter pylori, Mycoplasma pneumonia, Porphyromonas endodontalis, Porphyromonas gingivalis, Prevotella intermedia, Prevotella nigrescens, Pseudomonas aeruginosa, Pseudomonas luteola, Streptococcus gordonii, Streptococcus mitis, Streptococcus mutans, Streptococcus oralis, Streptococcus sanguinis, Treponema denticola, Tannerella forsythia, and Veillonella) along with relevant cardiovascular terms (Cardio∗, Cardiovascular, Cardiac, Heart, HF, Heart failure, Atherosclerosis, Athero∗, Arteri∗, Atherosclerotic, Coronary, atherosclerotic plaques, Endocarditis, Cardit∗, Aortic, Aort∗, Myocardial, and Myocardi∗).


## 2.3. Eligibility Criteria

Articles were imported into the EndNote software (version X7). Duplicate ones were automatically deleted from the dataset. Eligibility criteria were original studies on human samples published in English reporting microbial footprints in atherosclerotic plaques of coronary arteries. Studies published in other languages other than English, papers without full text, review articles, and articles presented in conferences as abstracts were excluded.


## 2.4. Quality Assessment

In order to assess the quality of the articles, a checklist prepared by The Joanna Briggs Institute (JBI) was used. The purpose of this appraisal is to assess the methodological quality of a study and to determine the extent to which a study has addressed the possibility of bias in its design, conduct, and analysis. All papers were evaluated on the basis of data relevance and methodological rigor.


## 2.5. Screening of the Articles

Primary searching of titles and abstracts was done by IRJ and ZE. They separately extracted data as well as evaluation of the articles’ quality control. In case of ambiguity in one article, the principal investigator issued the final decision.


## 2.6. Data Extraction Form

A predefined checklist was prepared in order to extract data from all eligible articles. This checklist contained the author name, publishing year, country of origin, method of microorganism detection, and prevalence of each isolated microorganism.


## 2.7. Statistical Analysis

Heterogeneity between studies and their combination were checked by the Cochran test andI2 parameter, respectively. In the case of heterogeneity, a random effect model with the inverse variance method was used. Otherwise, the fixed effect model was used. All the analyses were performed by CMA statistical software (ver. 2).


## 3. Results

### 3.1. Description of Search

Following searching of four defined databases (PubMed, ISI, SCOPUS, and Embase), 24343 articles were found which was decreased to 11382 after duplicate deletion. After screening their title and abstracts, 10862 articles were omitted owing to irrelevance to the study aim. The whole text of 520 papers was read and 44 were used for final analysis. It should be noted that references of the enrolled articles were screened as well to include eligible articles. The flowchart of the enrolled articles was depicted in Figure1. The characteristics of included studies were demonstrated in Table 1.Figure 1
Flowchart of the included eligible studies in the systematic review.Table 1
Basic characteristics of included studies.
OrderAuthor/yearCountryMethod of detectionPrevalence of isolated microorganism1Juvonen et al. /1996FinlandPCR, IHCCh. pneumoniae (65%)Total sample = 182Ouchi et al. /1997JapanPCR, IHCCh. pneumoniae (44%) by IHC Ch. pneumoniae (55%) by PCRTotal lesion = 293Song et al. /1999KoreaIHCCh. pneumoniae (57%)Total sample = 74Radke et al. /2000UKPCRCMV (30%),Ch. pneumoniae (32%), H. pylori (0%), Cytomegalovirus + Ch. pneumoniae (5%)Total lesion = 1065Farsak et al. /2000TurkeyPCRCh. pneumoniae (10%), H. pylori (50%), Ch. pneumoniae, and H. pylori (20%)Total lesion = 106Rassu et al. /2000ItalyPCR, IHCCMV (18%),H. pylori (40%)Total lesion = 187Choi et al. /2001KoreaPCRP. gingivalis (100%)Total lesion = 28Kowalski et al. /2001GermanyPCRH. pylori (42%)Total = 429Maraha et al. /2001NetherlandsPCR, IHCCh. pneumoniae (22% by PCR, 60% by IHC), M. pneumoniae (1%) by PCRTotal sample = 9510Stelzel et al. /2002GermanyPCRP. gingivalis (88.5%)Total sample = 2611Zamorano et al. /2002SpainPCRCh. pneumoniae (76%)Total lesion = 7612Ishihara et al. /2003Japan, USAPCRP. gingivalis (29%), P. intermedia (9%), E. faecalis (9%), P. nigrescens (9%), A. actinomycetemcomitans (3%), C. rectus (3%), T. forsythia (3%), P. endodontalis (1.9%), T. denticola (1.9%), F. nucleatum (0%)Total lesion = 5113Bahrmand et al. /2004IranPCRCh. pneumoniae (81%)Total lesion = 2214Arno et al. /2004UKPCRChlamydia species (71%)Total lesion = 3115Podsiadły et al. /2005PolandPCRCh. pneumoniae (26%)Total lesion = 4116Ott et al. /2004GermanyPCR, clones cultureChlamydia species (51.5%) by PCR, Ch. pneumoniae (%0), Ch. trachomatis (0%), H. pylori (0%), mycoplasma species (0%) by PCR Ch. pneumoniae (71%) by clones cultureTotal lesion = 3817Zaremba et al. /2006PolandPCRA. actinomycetemcomitans, (5%) P. intermedia (15%), P. gingivalis (50%), E. corrodens (15%), C. rectus (20%), T. forsythia (25%), T. denticola (30%), F. nucleatum (25%)Total lesion = 2018Zaremba et al. /2006PolandPCRPeriodontitis bacteria (55%)Total lesions = 2019Kilic et al. /2006TurkeyPCRH. pylori (23%), CMV (23%)Total sample = 3020Pucar et al. /2007SerbiaPCRP. gingivalis (53.33%), A. actinomycetemcomitans (26.67%), P. intermedia (33.33%), T. forsythia (13.33%), Cytomegaloviruses (66.67%), Ch. pneumoniae (33.33%) Total lesion = 1521Reszkaa et al. /2007PolandPCRCh. pneumoniae (27.5%), M. pneumoniae (15%), H. pylori (80%), herpes simplex viruses (67.5%)Total lesion = 4022Dabiri et al. /2008IranPCR, DIF (direct immunofluorescence)Ch. pneumoniae (19%)Total lesion = 2623Andriéa et al. /2009GermanyImmunhistochemistryCh. pneumoniae 73%, HP in 31%, CMV in 16%, and EBV in 40%.Total lesions = 6024Gaetti-Jardim et al. /2009BrazilPCRA. actinomycetemcomitans, F. nucleatum, P. gingivalis, P. intermedia, P. nigrescens, and T. forsythia, in 94.9% of the lesions. Te pathogens frequently found in coronary sites.Total lesion = 4425Mahendra et al. /2009IndiaPCRT. denticola (49.01%), E. corrodens (27.45%), C. rectus (21.51%), P. gingivalis (45.10%)Total patients = 5126Hem et al.IndiaPCRC. pneumoniae (58%), H. pylori (33%)Total lesion = 1227Silvia et al. /2010BrazilPCRP. gingivalis (50%), P. intermedia (16%), E. faecalis (16%), P. nigrescens (16%), A. actinomycetemcomitans (6%), C. rectus (6%), T. forsythia (6%), P. endodontalis (3%), T. denticola (3%), F. nucleatum (0%)Total lesion = 3028Mahendra et al. /2010IndiaPCRT. forsythia (11.8%), P. gingivalis (5.9%), P. gingivalis fimA (5.9%), P. nigrescens (5.9%) Total lesion = 5129Mahendra et al. /2010IndiaPCRT. denticola (49.01%), C. rectus (21.51%), P. gingivalis (45.10%) Total lesion = 5130Jegier et al. /2010JapanPCRFungal (40%), albicans (58%), mycotics (48%)Total lesion = 4031Koren et al. /2010USAPCRChryseomonas (100%), firmicutes (63.8%), bacteroidetes (11.7%), proteobacteria (15.4%), actinobacteria (6.4%)Total lesion = 1432Damodar et al. /2011BelgiumPCRCMV (30%), herpes simplex virus type 1 (5%) and herpes simplex virus type 2 (42.5%),H. pylori (12.5%), Ch. pneumoniae (22.5%)Total lesion = 4033Talebi ardakani et al. /2010IranPCRA. actinomycetemcomitans (90%), P. gingivalis (80%), P. intermedia (50%), T. forsythia (65%), T. denticola (55%), F. nucleatum (30%)Total lesion = 2034Izadi et al. /2011IranPCRH. pylori (29.5%) Total lesion = 10535Ohki et al. /2012JapanPCRA. actinomycetemcomitans (21.0%), P. gingivalis (3.7%), P. intermedia (0.0%), T. forsythia (0.0%), T. denticola (2.5%)Total lesion = 8136Sadeghian et al./2013IranPCRH. pylori (0%)Total lesion = 3037Calandrini et al. /2013BrazilPCRBetaproteo bacteria (21.7%), pseudomonadaceae (26.1%), alphaproteobacteria (13.0%)Total lesion = 3538Izadi et al. /2013IranPCRCh. pneumoniae and H. pylori (0%), CMV (30% in acute MI and 3.33% in nonacute MI)Total lesion = 1639Heybar et al. /2013IranPCRCMV (14.9%)Total sample = 11040Pessi et al. /2013FrancePCRStreptococcus sp. mainly S. mitis group (%72.3), A. actinomycetemcomitans (5.9%), P. gingivalis (5.0%), endodontic bacteria (78.2%), periodontal bacteria (34.6%)Total lesion = 941Saroj et al. /2014IndiaPCRA. actinomycetemcomitans (42.86%), P. gingivalis (71.43%), tannerella species (100%)Total lesion = 742Filho et al. /2014Canada, BrazilDNA amplification and cloningActinobacteria (10.0%), bacteroidetes (17.5%), firmicutes (17.5%), fusobacteria (5.0%), proteobacteria (45.0%),Prevotella intermedia 2.5%, synergistetes (0.0%), gracilibacteria (GNO2) 2.5%Total lesion = 4043Szulc et al. /2015PolandPCRP. gingivalis (9.4%)Total lesion = 3244Hansen et al. /2016DenmarkDNA FISHPositive bacteria (81%) identified a total of 55 different bacterial species.Total lesion = 22


### 3.2. Characteristics of the Included Studies

Based on geographical distribution, seven studies were conducted in Iran, five studies in Poland, five studies in India, three studies in Japan, four studies in Germany, four studies in Brazil, two studies in Korea, two studies in Turkey, two studies in the UK, and one study in Finland, Netherlands, Spain, Serbia, Belgium, France, Canada, Japan and USA, USA, and Denmark.


### 3.3. The Results of Meta-Analysis

The prevalence of different microorganisms in coronary arteries were as follows:Aggregatibacter actinomycetemcomitans (46.2%, 95% CI: 20.6–74.0, I2 = 92.2%, P value <0.001) (Figure 2), Campylobacter rectus (43.0%, 95% CI: 15.4–75.6, I2 = 91.7%, P value <0.001) (Figure 3), Chlamydia pneumonia (42.8%, 95% CI: 30.3–56.3, I2 = 92.4%, P value <0.001) (Figure 4), Cytomegalovirus (29.1%, 95% CI: 21.2–38.6, I2 = 56.7%, P value = 0.018) (Figure 5), Helicobacter pylori (18.9%, 95% CI: 10.5–31.7, I2 = 79%, P value <0.001) (Figure 6), Herpes simplex virus type 1 (5.9%, 95% CI: 1.9–16.8, I2 = 0.0%, P value = 0.667) (Figure 7), Porphyromonas gingivalis (42.6%, 95% CI: 21.6–66.6, I2 = 92.1%, P value <0.001) (Figure 8), Prevotella intermedia (47.6%, 95% CI: 18.4–78.5, I2 = 88.2%, P value <0.001) (Figure 9), Tannerella forsythia (43.7%, 95% CI: 15.0–77.4, I2 = 91.2%, P-value <0.001) (Figure 10), and Treponema denticola (32.9%, 95% CI: 16.5–54.9, I2 = 85.9%, P value <0.001) (Figure 11).Figure 2
The prevalence ofAggregatibacter actinomycetemcomitans in atherosclerotic plaques of coronary arteries.Figure 3
The prevalence ofCampylobacter rectus in atherosclerotic plaques of coronary arteries.Figure 4
The prevalence ofChlamydia pneumoniae in atherosclerotic plaques of coronary arteries.Figure 5
The prevalence ofCytomegalovirus in atherosclerotic plaques of coronary arteries.Figure 6
The prevalence ofHelicobacter pylori in atherosclerotic plaques of coronary arteries.Figure 7
The prevalence of Herpes simplex virus type 1 in atherosclerotic plaques of coronary arteries.Figure 8
The prevalence ofPorphyromonas gingivalis in atherosclerotic plaques of coronary arteries.Figure 9
The prevalence ofPrevotella intermedia in atherosclerotic plaques of coronary arteries.Figure 10
The prevalence ofTannerella forsythia in atherosclerotic plaques of coronary arteries.Figure 11
The prevalence ofTreponema denticola in atherosclerotic plaques of coronary arteries.


## 3.1. Description of Search

Following searching of four defined databases (PubMed, ISI, SCOPUS, and Embase), 24343 articles were found which was decreased to 11382 after duplicate deletion. After screening their title and abstracts, 10862 articles were omitted owing to irrelevance to the study aim. The whole text of 520 papers was read and 44 were used for final analysis. It should be noted that references of the enrolled articles were screened as well to include eligible articles. The flowchart of the enrolled articles was depicted in Figure1. The characteristics of included studies were demonstrated in Table 1.Figure 1
Flowchart of the included eligible studies in the systematic review.Table 1
Basic characteristics of included studies.
OrderAuthor/yearCountryMethod of detectionPrevalence of isolated microorganism1Juvonen et al. /1996FinlandPCR, IHCCh. pneumoniae (65%)Total sample = 182Ouchi et al. /1997JapanPCR, IHCCh. pneumoniae (44%) by IHC Ch. pneumoniae (55%) by PCRTotal lesion = 293Song et al. /1999KoreaIHCCh. pneumoniae (57%)Total sample = 74Radke et al. /2000UKPCRCMV (30%),Ch. pneumoniae (32%), H. pylori (0%), Cytomegalovirus + Ch. pneumoniae (5%)Total lesion = 1065Farsak et al. /2000TurkeyPCRCh. pneumoniae (10%), H. pylori (50%), Ch. pneumoniae, and H. pylori (20%)Total lesion = 106Rassu et al. /2000ItalyPCR, IHCCMV (18%),H. pylori (40%)Total lesion = 187Choi et al. /2001KoreaPCRP. gingivalis (100%)Total lesion = 28Kowalski et al. /2001GermanyPCRH. pylori (42%)Total = 429Maraha et al. /2001NetherlandsPCR, IHCCh. pneumoniae (22% by PCR, 60% by IHC), M. pneumoniae (1%) by PCRTotal sample = 9510Stelzel et al. /2002GermanyPCRP. gingivalis (88.5%)Total sample = 2611Zamorano et al. /2002SpainPCRCh. pneumoniae (76%)Total lesion = 7612Ishihara et al. /2003Japan, USAPCRP. gingivalis (29%), P. intermedia (9%), E. faecalis (9%), P. nigrescens (9%), A. actinomycetemcomitans (3%), C. rectus (3%), T. forsythia (3%), P. endodontalis (1.9%), T. denticola (1.9%), F. nucleatum (0%)Total lesion = 5113Bahrmand et al. /2004IranPCRCh. pneumoniae (81%)Total lesion = 2214Arno et al. /2004UKPCRChlamydia species (71%)Total lesion = 3115Podsiadły et al. /2005PolandPCRCh. pneumoniae (26%)Total lesion = 4116Ott et al. /2004GermanyPCR, clones cultureChlamydia species (51.5%) by PCR, Ch. pneumoniae (%0), Ch. trachomatis (0%), H. pylori (0%), mycoplasma species (0%) by PCR Ch. pneumoniae (71%) by clones cultureTotal lesion = 3817Zaremba et al. /2006PolandPCRA. actinomycetemcomitans, (5%) P. intermedia (15%), P. gingivalis (50%), E. corrodens (15%), C. rectus (20%), T. forsythia (25%), T. denticola (30%), F. nucleatum (25%)Total lesion = 2018Zaremba et al. /2006PolandPCRPeriodontitis bacteria (55%)Total lesions = 2019Kilic et al. /2006TurkeyPCRH. pylori (23%), CMV (23%)Total sample = 3020Pucar et al. /2007SerbiaPCRP. gingivalis (53.33%), A. actinomycetemcomitans (26.67%), P. intermedia (33.33%), T. forsythia (13.33%), Cytomegaloviruses (66.67%), Ch. pneumoniae (33.33%) Total lesion = 1521Reszkaa et al. /2007PolandPCRCh. pneumoniae (27.5%), M. pneumoniae (15%), H. pylori (80%), herpes simplex viruses (67.5%)Total lesion = 4022Dabiri et al. /2008IranPCR, DIF (direct immunofluorescence)Ch. pneumoniae (19%)Total lesion = 2623Andriéa et al. /2009GermanyImmunhistochemistryCh. pneumoniae 73%, HP in 31%, CMV in 16%, and EBV in 40%.Total lesions = 6024Gaetti-Jardim et al. /2009BrazilPCRA. actinomycetemcomitans, F. nucleatum, P. gingivalis, P. intermedia, P. nigrescens, and T. forsythia, in 94.9% of the lesions. Te pathogens frequently found in coronary sites.Total lesion = 4425Mahendra et al. /2009IndiaPCRT. denticola (49.01%), E. corrodens (27.45%), C. rectus (21.51%), P. gingivalis (45.10%)Total patients = 5126Hem et al.IndiaPCRC. pneumoniae (58%), H. pylori (33%)Total lesion = 1227Silvia et al. /2010BrazilPCRP. gingivalis (50%), P. intermedia (16%), E. faecalis (16%), P. nigrescens (16%), A. actinomycetemcomitans (6%), C. rectus (6%), T. forsythia (6%), P. endodontalis (3%), T. denticola (3%), F. nucleatum (0%)Total lesion = 3028Mahendra et al. /2010IndiaPCRT. forsythia (11.8%), P. gingivalis (5.9%), P. gingivalis fimA (5.9%), P. nigrescens (5.9%) Total lesion = 5129Mahendra et al. /2010IndiaPCRT. denticola (49.01%), C. rectus (21.51%), P. gingivalis (45.10%) Total lesion = 5130Jegier et al. /2010JapanPCRFungal (40%), albicans (58%), mycotics (48%)Total lesion = 4031Koren et al. /2010USAPCRChryseomonas (100%), firmicutes (63.8%), bacteroidetes (11.7%), proteobacteria (15.4%), actinobacteria (6.4%)Total lesion = 1432Damodar et al. /2011BelgiumPCRCMV (30%), herpes simplex virus type 1 (5%) and herpes simplex virus type 2 (42.5%),H. pylori (12.5%), Ch. pneumoniae (22.5%)Total lesion = 4033Talebi ardakani et al. /2010IranPCRA. actinomycetemcomitans (90%), P. gingivalis (80%), P. intermedia (50%), T. forsythia (65%), T. denticola (55%), F. nucleatum (30%)Total lesion = 2034Izadi et al. /2011IranPCRH. pylori (29.5%) Total lesion = 10535Ohki et al. /2012JapanPCRA. actinomycetemcomitans (21.0%), P. gingivalis (3.7%), P. intermedia (0.0%), T. forsythia (0.0%), T. denticola (2.5%)Total lesion = 8136Sadeghian et al./2013IranPCRH. pylori (0%)Total lesion = 3037Calandrini et al. /2013BrazilPCRBetaproteo bacteria (21.7%), pseudomonadaceae (26.1%), alphaproteobacteria (13.0%)Total lesion = 3538Izadi et al. /2013IranPCRCh. pneumoniae and H. pylori (0%), CMV (30% in acute MI and 3.33% in nonacute MI)Total lesion = 1639Heybar et al. /2013IranPCRCMV (14.9%)Total sample = 11040Pessi et al. /2013FrancePCRStreptococcus sp. mainly S. mitis group (%72.3), A. actinomycetemcomitans (5.9%), P. gingivalis (5.0%), endodontic bacteria (78.2%), periodontal bacteria (34.6%)Total lesion = 941Saroj et al. /2014IndiaPCRA. actinomycetemcomitans (42.86%), P. gingivalis (71.43%), tannerella species (100%)Total lesion = 742Filho et al. /2014Canada, BrazilDNA amplification and cloningActinobacteria (10.0%), bacteroidetes (17.5%), firmicutes (17.5%), fusobacteria (5.0%), proteobacteria (45.0%),Prevotella intermedia 2.5%, synergistetes (0.0%), gracilibacteria (GNO2) 2.5%Total lesion = 4043Szulc et al. /2015PolandPCRP. gingivalis (9.4%)Total lesion = 3244Hansen et al. /2016DenmarkDNA FISHPositive bacteria (81%) identified a total of 55 different bacterial species.Total lesion = 22


## 3.2. Characteristics of the Included Studies

Based on geographical distribution, seven studies were conducted in Iran, five studies in Poland, five studies in India, three studies in Japan, four studies in Germany, four studies in Brazil, two studies in Korea, two studies in Turkey, two studies in the UK, and one study in Finland, Netherlands, Spain, Serbia, Belgium, France, Canada, Japan and USA, USA, and Denmark.


## 3.3. The Results of Meta-Analysis

The prevalence of different microorganisms in coronary arteries were as follows:Aggregatibacter actinomycetemcomitans (46.2%, 95% CI: 20.6–74.0, I2 = 92.2%, P value <0.001) (Figure 2), Campylobacter rectus (43.0%, 95% CI: 15.4–75.6, I2 = 91.7%, P value <0.001) (Figure 3), Chlamydia pneumonia (42.8%, 95% CI: 30.3–56.3, I2 = 92.4%, P value <0.001) (Figure 4), Cytomegalovirus (29.1%, 95% CI: 21.2–38.6, I2 = 56.7%, P value = 0.018) (Figure 5), Helicobacter pylori (18.9%, 95% CI: 10.5–31.7, I2 = 79%, P value <0.001) (Figure 6), Herpes simplex virus type 1 (5.9%, 95% CI: 1.9–16.8, I2 = 0.0%, P value = 0.667) (Figure 7), Porphyromonas gingivalis (42.6%, 95% CI: 21.6–66.6, I2 = 92.1%, P value <0.001) (Figure 8), Prevotella intermedia (47.6%, 95% CI: 18.4–78.5, I2 = 88.2%, P value <0.001) (Figure 9), Tannerella forsythia (43.7%, 95% CI: 15.0–77.4, I2 = 91.2%, P-value <0.001) (Figure 10), and Treponema denticola (32.9%, 95% CI: 16.5–54.9, I2 = 85.9%, P value <0.001) (Figure 11).Figure 2
The prevalence ofAggregatibacter actinomycetemcomitans in atherosclerotic plaques of coronary arteries.Figure 3
The prevalence ofCampylobacter rectus in atherosclerotic plaques of coronary arteries.Figure 4
The prevalence ofChlamydia pneumoniae in atherosclerotic plaques of coronary arteries.Figure 5
The prevalence ofCytomegalovirus in atherosclerotic plaques of coronary arteries.Figure 6
The prevalence ofHelicobacter pylori in atherosclerotic plaques of coronary arteries.Figure 7
The prevalence of Herpes simplex virus type 1 in atherosclerotic plaques of coronary arteries.Figure 8
The prevalence ofPorphyromonas gingivalis in atherosclerotic plaques of coronary arteries.Figure 9
The prevalence ofPrevotella intermedia in atherosclerotic plaques of coronary arteries.Figure 10
The prevalence ofTannerella forsythia in atherosclerotic plaques of coronary arteries.Figure 11
The prevalence ofTreponema denticola in atherosclerotic plaques of coronary arteries.


## 4. Discussion

At present, CAD is a worldwide cause of hospitalization and mortality [6]. Beside well-established risk factors such as genetic susceptibility, hypertension, hypercholesterolemia, and smoking, the risk of atherosclerotic vascular disease is increased by microbial infection [8]. For the first time, the association of microbial infection with atherosclerosis was demonstrated by Marek’s disease virus. This virus induced atherosclerosis in chickens [9]. To substantiate, vaccination against this virus significantly protected chickens from atherosclerosis [10]. The human microbiome which mainly accumulates in the gut and oral cavity has an outstanding role to human health. Pathogens were found in thrombotic samples of MI patients [11]. Other than CVD, this huge microbial population is also involved in cardiovascular risk factors such as obesity and diabetes [12–15].The potential of pathogens in promoting chronic disorders even in remote organs like colon cancers and atherosclerosis has been evidenced [16]. That is why chronic periodontal infection is in close relation to acute myocardial infarction (MI) and CAD [17, 18]. It may be interesting if you know that more than 275 oral bacterial species could enter the bloodstream through injured capillaries [19, 20]. Oral biofilm is in close proximity to the periodontal vasculature, and this makes the entrance and spread of bacteria feasible even to remote organs like the heart [21]. Indeed, in the case of inflammation (periodontitis or gingivitis), bacterial entrance is further smoothed due to increased permeability of the adjacent vessels [22]. Following bacterial access to the bloodstream, they could be localized in different parts of the human body, especially in sites with pathologic changes [23, 24]. In one study, subgingival plaques and different blood vessels of patients with atherosclerosis and periodontitis were sought in order to determine the frequency of periodontal bacteria. Findings revealed that the most and the least prevalent bacteria were Tannerella forsythensis and Treponema denticola, respectively. Also, the prevalence of A. actinomycetemcomitans and Prevotella intermedia were significantly different between subjects below and over 60 years of age [25].The role of certain microbial infections such asC. pneumoniae, P. gingivalis, A. actinomycetemcomitans, H. pylori, influenza virus, and cytomegalovirus has been confirmed in the development of atherosclerosis in animal models [4]. Infection of vascular cells, detection of the microbes within the atherosclerotic plaque, and the development of atherosclerotic lesions after microbial infection in animal models reinforce the direct association of infection with atherosclerosis. On the other hand, indirect effects represent the emergence of cytokines and acute phase proteins followed by infection at nonvascular sites [4].Infection with the Influenza virus increases the risk of the acute coronary syndrome and fatal MI [26]. Bacterial footprints were found from specimens of the heart valve and even aortic aneurysm [27]. A high amount of S. mutans has been detected concurrently in the heart valve samples, dental plaque, and saliva samples [28]. The presence of oral pathogens like streptococci and Porphyromonas gingivalis has been reported in atherosclerotic plaques of the carotid artery [29]. Also, bacterial genomes or their ribosomal DNA have been detected in atherosclerotic lesions of different arteries like aorta or coronary [30–34]. Nucleic acid or antigens of a wide range of pathogens, either bacteria or viruses, were found in atherosclerotic plaques [35–53]. Our studies show the presence of different pathogens (bacteria and virus) in the atherosclerotic plaques of coronary arteries. Unless herpes simplex virus type I, the existence of other pathogens is statistically significant. This may show the implication of a microbial center for the initiation and development of atherosclerotic plaque. However, this should be assessed by further comprehensive studies at the cellular and molecular level.Several studies reported the presence of more than one pathogen in atherosclerotic plaques [29, 30, 37, 38, 40, 41, 46, 54, 55]. The simultaneous existence of some bacteria synergistically enhances their virulence [16]. Virulence factors of bacteria including fimbriae, degradative enzymes, exopolysaccharide capsules, toxins, and atypical lipopolysaccharides trigger the process of inflammation and affect vital organs like the cardiovascular system [56–58]. These adverse effects will be more detrimental in mixed infections [59–64].The immune system is a major part of atherosclerosis progression. Microbial infection instigates immune responses [65]. Production of antibody is emerged after bacterial infections. This immune reaction increases the expression of inflammatory mediators, which in turn involves in the development of coronary thrombosis [65]. Also, microbial infections, either bacterial or viral, activate vessel-associated leucocytes [65]. The binding of bacterial-associated molecular patterns to Toll-like receptors triggers a signaling pathway, which upregulates some genes with a key role in atherogenesis (adhesion molecules in endothelial cells and inflammatory mediators in immune cells) [66]. Some bacteria like P. gingivalis accelerate atherosclerosis through enhancing the Th17 responses [3]. A specific immune response and aortic inflammation are raised with chronic oral P. gingivalis infection [67].Activation of platelets by bacteria results in thrombosis formation [1, 68]. Some bacteria like streptococci are endothelial-adhesive. This facilitates embedding to the damaged heart valves and subsequent thrombosis induction [65]. Consequent inflammation and vascular changes may terminate to the functional impairment of both endothelial cells and smooth muscles of coronary arteries [69, 70].It seems that the entry of bacteria and other microbiome populations into the bloodstream is a continuous flow which inevitably leads to a surge in the expression of inflammatory cytokines and chemokines. These factors could be drivers of CAD [71]. For example, it was shown that bacterial lipopolysaccharide (LPS) upregulates LDL levels, increasing the risk of CAD [72]. Indeed, the remnants of bacteria like DNA or membrane phospholipids provoke CAD via modulating adipose or vascular tissues [6]. However, it was reported that the development of atherosclerotic lesions is largely accelerated by live organisms rather than heat-killed ones or their LPS [73]. Reports on successful culturing of pathogens after their isolation from atheroma only existed about C. pneumoniae and E. hormaechei [74–77].Overall, it does not clearly understand if initiation or progression of atherosclerosis is dependent on the presence of microbes. In an interesting study, the bacterial profile of atherosclerotic plaques was compared between symptomatic and asymptomatic CAD patients. Neither the amount of bacterial DNA nor microbial composition was not different between the two groups. It was concluded that the vulnerability of plaques may be influenced by other factors [1]. In vitro studies demonstrated that invasive strains of P.gingivalis help foam cell formation which is a pivotal step in the evolution of atherosclerotic plaques [78]. Although the role of bacteria like Chlamydia pneumoniae has been suggested in this process [79], antibacterial therapy did not address atherosclerotic-related complications [80].In spite of acceptable evidence on the role of microbial infection in atherosclerosis, which is derived mostly from animal models, it seems that assigning a definitive determining role as equal as other cardiovascular risk factors for the development of atherosclerosis in humans is debated and there are numerous questions that need to be answered in this area [4].Our study tried to cover almost all the published data on this subject. However, we should consider the possibility of unintentional mistakes to include qualified papers among hundreds of screened papers.


## 5. Conclusion

Undoubtedly, microbes contribute substantially to human hemostasis. However, access to these elements in some sites may stimulate adverse events. It is important to elucidate the role of microbes in CAD as atherosclerosis imposes a huge health burden. This needs to be addressed in order to save resources for the rainy days and unprecedented diseases.



---

*Source: 8678967-2022-12-01.xml*